Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Short-term Investments (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Short-term Investments for 11 consecutive years, with $7.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments rose 25.05% year-over-year to $7.5 million, compared with a TTM value of $7.5 million through Oct 2025, up 25.05%, and an annual FY2025 reading of $7.5 million, up 25.05% over the prior year.
  • Short-term Investments was $7.5 million for Q4 2025 at Pharma-Bio Serv, up from $6.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $11.7 million in Q3 2023 and bottomed at $4.5 million in Q4 2023.
  • Average Short-term Investments over 3 years is $7.5 million, with a median of $7.1 million recorded in 2025.
  • The sharpest move saw Short-term Investments skyrocketed 80.98% in 2024, then crashed 45.89% in 2025.
  • Year by year, Short-term Investments stood at $4.5 million in 2023, then skyrocketed by 31.93% to $6.0 million in 2024, then grew by 25.05% to $7.5 million in 2025.
  • Business Quant data shows Short-term Investments for PBSV at $7.5 million in Q4 2025, $6.8 million in Q3 2025, and $8.3 million in Q2 2025.